arrow
C

Carla Boccaccio

irccs- humanitas research hospital
H指数:35
被引数:5,615

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma

由于miR-205失活导致的ERBB3过表达赋予胶质母细胞瘤对FGF的敏感性、代谢激活以及对ERBB3靶向的易感性

2026-09-100
OAAI
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing

雄激素受体抑制通过miR-1/miR-26a-1/miR-487b特征介导的WT1和FOXA1沉默,使胶质母细胞瘤干细胞对替莫唑胺更敏感。

2025-05-210
OA
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study
2025-02-010
OAAI
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription

RB1和P53通路的同时性破坏会促使高级别胶质瘤中依赖MYC驱动的EBF3转录的原始神经元成分的发展。

2025-01-160
PRE
Phase II study of consolidation treatment with holmium-166 (166Ho) TARE followed by maintenance systemic therapy (MT) in unresectable liver-limited (ULL) colorectal cancer (CRC) patients (pts) after standard first-line induction therapy: The HAITI trial
2024-06-010
PRE
Systemic inflammation in liver vs non-liver metastatic microsatellite stable (MSS) colorectal cancer (CRC): An analysis of 2186 patients (pts) from the observational study BMI-QoL and the phase II and III trials MACBETH, MOMA, ATEZOTRIBE, TRIBE, TRIBE2, TRIPLETE
2024-06-010
PRE
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas
2023-08-015
OA
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2023-01-1718
OAAI
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

诊断不明原发癌 (CUPs) 的恶性肿瘤的真实世界组织病理学方法

2022-11-0815
OAAI
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma
2021-07-0118
OAAI
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype
2020-08-0540
OAAI